Hologic Inks $205M Sale Of 'Underperforming' Med Tech Co.
Hologic detailed plans Wednesday to sell its "underperforming" medical aesthetics company Cynosure for $205 million to private equity firm Clayton Dubilier & Rice, in a deal steered by Wachtell and Debevoise....To view the full article, register now.
Already a subscriber? Click here to view full article